Friday, February 1, 2013 |
|
09:00 |
Registration and Distribution of Material |
14:20 |
Opening Remarks Ian A. Greer, United Kingdom; Benjamin Brenner, Israel |
14:30 - 15:45 |
HORMONAL THERAPY Chairs: Sabine Eichinger-Hasenauer, Austria & Jacqueline Conard, France |
14:30 |
Observational studies of hormonal therapy and thrombosis: Methodological issues Samy Suissa, Canada |
14:55 |
Mechanisms of hormonal therapy related thrombosis Per Morten Sandset, Norway |
15:20 |
Selected Oral Communications 1) Venous thromboembolism in relation to in-vitro fertilization–An approach to determining the incidence and increase in risk in successful cycles; Rova K, Passmark H, Lindqvist PG; Sweden 2) Risk of recurrent venous thromboembolism associated with female hormone intake – a prospective cohort study; Eischer L, Eichinger S, Kyrle PA; Austria 3) Oral contraception and risk of venous thromboembolism within the first year following pregnancy; Petersen JF, Bergholt T, Nielsen AK, Lidegaard Ø, Paidas MJ, Løkkegaard ECL.; Denmark & USA |
15:45 |
COFFEE BREAK |
|
|
16:15 - 17:45 |
ARTERIAL THROMBOSIS Chairs: Risto Kaaja, Finland & Emmanouil Papadakis, Greece |
16:15 |
Thrombotic microangiopathy Flora Peyvandi, Italy |
16:40 |
Mechanical heart valves Claire McLintock, New Zealand |
17:05 |
Management of pregnant women with myeloproliferative neoplasms Benjamin Brenner, Israel |
17:30 |
Selected Oral Communications 1) Gender aspects of fibrin clot structure in patients with type 1 diabetes mellitus; Tehrani S, Wallen NH, Elgue G, Majeed K, Henriksson P, Ågren A, Adamson U, Lins PE, Jörneskog G, Antovic A; Sweden 2) Pregnancy and labour in patients with history of arterial thrombosis; Makatsariya AD, Bitsadze VO, Akinshina SV, Khizroeva DKh, Gadaeva ZK; Russia |
17:45 - 19:00 |
POSTER SESSION |
|
|
20:00 - 22:00 |
GET-TOGETHER RECEPTION |
Saturday, February 2, 2013 |
|
08:30 - 10:00 |
PLACENTAL AND FETAL HAEMOSTASIS Chairs: Beatriz E. Grand, Argentina & Paolo Simioni, Italy |
08:30 |
Developmental haemostasis Berend Isermann, Germany |
08:55 |
Placental vascular lesions Michal Kovo, Israel |
09:20 |
Placenta-derived microparticles Anat Aharon, Israel |
09:45 |
Selected Oral Communications 1) Effects of Low Molecular Heparin within the Uteroplacental Unit; Ismail SK, Norris L, Kelly L, Higgins JR; Ireland 2) Inhibitor of PAI-1 prevents abortion in CBA/J x DBA/2 mice model; Marwan O, Ben Haroush S, Palzur E, Al-Roof Higazi A, Bornstein J; Israel |
10:00 |
COFFEE BREAK |
|
|
10:30 - 12:05 |
PREGNANCY COMPLICATIONS Chairs: Saskia Middeldorp, the Netherlands & Michael Kupferminc, Israel |
10:30 |
Thrombophilia and placenta-mediated complications Marc A. Rodger, Canada |
10:55 |
Antiphospholipid syndrome Jean-Christophe Gris, France |
11:20 |
Pathogenesis and management of peritpartum calamities (DIC and AFE) Marcel Levi, the Netherlands |
11:45 |
Selected Oral Communications 1) Prevention of pregnancy loss in carriers of thrombophilia: The OTTILIA study; Grandone E, Villani M, De Stefano V, Ageno W, Falasca A, Puggina P, Tranquilli A, Martinelli P, Margaglione M; Italy 2) Low Molecular Weight Heparin in Recurrent Pregnancy Loss – Results of the ETHIG II Study; Schleussner E, Kamin G, Seeliger G, Rogenhofer N, Toth B for the ETHIG Investigator Group; Germany 3) ALIFE2 Study: Call for partipation; Middeldorp S; the Netherlands |
12:05 – 13:55 |
LUNCH BREAK |
|
|
12:35 – 13:55 |
LUNCH SYMPOSIUM Management of Pregnancy Complications Chairs: Benjamin Brenner, Israel & Jean-Christophe Gris, France |
12:35 |
Epidemiology of preeclampsia Jean-Christophe Gris, France |
12:50 |
Antithrombotics for pregnancy complications Ian A. Greer, United Kingdom |
13:05 |
Prevention of maternal and perinatal complications by enoxaparin in women with previous severe preeclampsia Bassam Haddad, France |
13:20 |
Global tests of coagulation in pregnancy Paolo Simioni, Italy |
13:35 |
Round Table |
|
|
13:55 - 15:20 |
NEONATAL HAEMOSTASIS Chairs: Silvia Hoirisch-Clapauch, Brazil & Simcha Yagel, Israel |
13:55 |
Intraventricular hemorrhage Gili Kenet, Israel |
14:20 |
Neonatal thrombosis Ulrike Nowak-Göttl, Germany |
14:45 |
Neonatal alloimmune thrombocytopenia Ulrich Sachs, Germany |
15:10 |
Selected Oral Communications 1) Correlation between isolated fetal cerebral ventriculomegaly and fetal and neonatal alloimmune thrombocytopenia; Martillotti G, Rypens F, David M, Catalfamo N, Désilet V, Dubé J, Taillefer C, Lachance C, Audibert F; Canada |
15:20 |
COFFEE BREAK |
|
|
15:50 - 17:25 |
BLEEDING IN WOMEN Chairs: Rochelle Winikoff, Canada & Grigoris T. Gerotziafas, France |
15:50 |
Recent advances in the management of ITP Roberto Stasi, United Kingdom |
16:15 |
Von Willebrand Disease: pathogenesis and management Francesco Rodeghiero, Italy |
16:40 |
Post-partum hemorrhage Alexander Makatsaria, Russia |
17:05 |
Selected Oral Communications 1) Is a Pbac-Score a Good Tool to Quantify Menorrhagia in Women with Von Willebrand Disease and Rare Bleeding Disorders?; Halimeh S, Rott H; Germany 2) rhuFVIIa in women with a refractory primary postpartum haemorrhage: an international, multicenter, randomised, opened, controlled trial; Lavigne-Lissalde G, Aya G, Mercier F, Roger-Christophe S, Chauleur C, Morau E, Ducloys A-S, Mignon A, Raucoule M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Castelli C, Fabbro-Perray P, Gris J-C; France & Switzerland 3) Investigation of underlying platelet function defects in patients with unexplained menorrhagia; Lowe G, Lordkipanidzé M, Dawood B, Clark J, Lester W, Watson SP on behalf of the UK GAPP study; United Kingdom |
20:00 |
FAREWELL DINNER (optional) |
Sunday, February 3, 2013 |
|
08:30 – 10:00 |
VENOUS THROMBOEMBOLISM Chairs: Gregoire Le Gal, Canada & Amparo Santamaria, Spain |
08:30 |
Thrombosis during assisted reproduction Scott M Nelson, United Kingdom |
08:55 |
Cerebral vein thrombosis Ida Martinelli, Italy |
09:20 |
Pregnancy and travel-related thromboembolism Suzanne C. Cannegieter, the Netherlands |
09:45 |
Selected Oral Communications 1) Pregnancy related thrombosis risk in patients with protein C deficiency; Rugeri L, Kouatra L, Arnuti B, Miranda P, Trzeciak MC, Vergnes C, Dargaud Y; France 2) Venous thromboembolism after delivery: Trends in national readmission rates between 2002 and 2012; Lester W, Begaj I, Ray D, Pagano D; United Kingdom 3) Differential risk factors for pregnancy-related deep vein thrombosis and pulmonary embolism – Results from a population-based case-control study; Bergrem A, Dahm AE.A., Jacobsen A-F, Sandvik L, Sandset PM; Norway |
10:00 |
COFFEE BREAK |
|
|
10:30 – 12:00 |
THROMBOSIS AND CANCER Chairs: Per Morten Sandset, Norway & Armando D’Angelo, Italy |
10:30 |
Epidemiology of cancer and thrombosis in women Ingrid Pabinger, Austria |
10:55 |
Mechanisms of thrombosis in cancer Anna Falanga, Italy |
11:20 |
International guidelines for anticoagulant management in cancer patients Dominique Farge-Bancel, France |
11:45 |
Selected Oral Communications 1) Long-term mortality and incidence of cancer after pregnancy-related venous thrombosis (VT): results of a population-based, prospective cohort study; Wik HS, Jacobsen A-F, Wang Fagerland M, Sandvik L, Sandset PM; Norway 2) The link between the hemostatic system and cancer: A genotype-phenotype study in breast cancer patients; Tinholt M, Viken MK, Børresen-Dale AL, Kristensen V, Kåresen R, Schlichting E, Garred Ø, Lie BA, Dahm AE, Skretting G, Sandset PM, Iversen N; Norway |
12:00 – 13:50 |
LUNCH BREAK |
|
|
12:30 – 13:50 |
LUNCH SYMPOSIUM Thrombosis in Women Chairs: Ian A. Greer, United Kingdom & Ida Martinelli, Italy |
12:30 |
Introduction: Setting the stage Ida Martinelli, Italy |
12:35 |
Acute coronary syndrome: Are women appropriately taken care of? Ariel Roguin, Israel |
12:50 |
VTE prophylaxis in acutely ill medical patients: Should women be treated longer? Jacqueline Conard, France |
13:05 |
Gynecological cancer surgery – How long to treat? Risto Kaaja, Finland |
13:20 |
Bariatric surgery thromboprophylaxis in women Emmanuel Papadakis, Greece |
13:35 |
Round Table |
|
|
13:50 - 15:20 |
NEW ANTICOAGULANTS Chairs: Rupert M. Bauersachs, Germany & Marc Rodger, Canada |
13:50 |
New anticoagulants in atrial fibrillation management Sam Schulman, Canada |
14:15 |
New anticoagulants in surgical patients Walter Ageno, Italy |
14:40 |
Thromboprophylaxis in cancer patients Melina Verso, Italy |
15:05 |
Selected Oral Communications 1) Antithrombothic prophylaxis and ART procedures: an Italian prospective cohort study; Grandone E, Villani M, Tiscia GL, Dentali F, Colaizzo D, Cappucci F, Fischetti L, Ageno W, Margaglione M; Italy 2) Effects of LMWH prophylaxis on the morbidly obese pregnant women; Ismail SK, Norris L, O’Shea, Higgins JR; Ireland |
15:20 15:30 |
Concluding Remarks: Ian A. Greer, United Kingdom; Benjamin Brenner, Israel MEETING ADJOURNED |